 | Up a level |
Wollenberg, A; Flohr, C; Simon, Dagmar; Cork, M J; Thyssen, J P; Bieber, T; de Bruin-Weller, M S; Weidinger, S; Deleuran, M; Taieb, A; Paul, C; Trzeciak, M; Werfel, T; Seneschal, J; Barbarot, S; Darsow, U; Torrelo, A; Stalder, J-F; Svensson, Å; Hijnen, D; ... (2020). European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis. Journal of the European Academy of Dermatology and Venereology : JEADV, 34(6), e241-e242. Wiley 10.1111/jdv.16411
Bieber, T; Akdis, C; Lauener, R; Traidl-Hoffmann, C; Schmid-Grendelmeier, P; Schäppi, G; Allam, J-P; Apfelbacher, C; Augustin, M; Beck, L; Biedermann, T; Braun-Fahrländer, C; Chew, F T; Clavel, T; Crameri, R; Darsow, U; Deleuran, M; Dittlein, D; Duchna, H-W; Eichenfeld, L; ... (2016). Global Allergy Forum and 3rd Davos Declaration 2015: Atopic dermatitis/Eczema: challenges and opportunities toward precision medicine. Allergy, 71(5), pp. 588-592. Wiley-Blackwell 10.1111/all.12857
Mrowietz, U; Kragballe, K; Reich, K; Spuls, P; Griffiths, C E M; Nast, A; Franke, J; Antoniou, C; Arenberger, P; Balieva, F; Bylaite, M; Correia, O; Daudén, E; Gisondi, P; Iversen, L; Kemény, L; Lahfa, M; Nijsten, T; Rantanen, T; Reich, A; ... (2011). Definition of treatment goals for moderate to severe psoriasis: a European consensus. Archives of dermatological research, 303(1), pp. 1-10. Berlin: Springer 10.1007/s00403-010-1080-1
